Insider · CIK 0001817217

van Houte Hans

CIK 0001817217 Name as filed on the most recent filing

Filed as van Houte Hans (35)

45 transaction lines · from 35 filings · filed 2021-02-22 to 2026-08-04 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

45 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-08-04 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 115,989, disposed Open Form 4 filing 0001817217-26-000012
2026-07-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 66,524, disposed Open Form 4 filing 0001817217-26-000010
2026-05-05 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 233,319, disposed Open Form 4 filing 0001817217-26-000008
2026-04-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 39,749, disposed Open Form 4 filing 0001817217-26-000006
2026-01-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 60,767, disposed Open Form 4 filing 0001817217-26-000002
2025-11-03 S, Open-market sale Nurix Therapeutics, Inc.NRIX 78,931, disposed Open Form 4 filing 0001817217-25-000005
2025-10-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 40,054, disposed Open Form 4 filing 0001817217-25-000003
2025-08-01 S, Open-market sale Nurix Therapeutics, Inc.NRIX 59,598, disposed Open Form 4 filing 0001549595-25-000103
2025-07-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 51,695, disposed Open Form 4 filing 0001549595-25-000101
2025-05-02 S, Open-market sale Nurix Therapeutics, Inc.NRIX 70,243, disposed Open Form 4 filing 0001549595-25-000063
2025-04-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 28,041, disposed Open Form 4 filing 0001549595-25-000059
2025-03-03 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 84,388, disposed Open Form 4 filing 0001549595-25-000037
2025-01-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 55,809, disposed Open Form 4 filing 0001549595-25-000020
2024-11-01 S, Open-market sale Nurix Therapeutics, Inc.NRIX 86,083, disposed Open Form 4 filing 0001549595-24-000153
2024-10-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 57,554, disposed Open Form 4 filing 0001549595-24-000148
2024-08-26 S, Open-market sale Nurix Therapeutics, Inc.NRIX 504,370, disposed Open Form 4 filing 0001549595-24-000112
2024-08-01 S, Open-market sale Nurix Therapeutics, Inc.NRIX 2 lines 74,576, disposed Open Form 4 filing 0001549595-24-000110
2024-07-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 51,463, disposed Open Form 4 filing 0001549595-24-000104
2024-06-20 S, Open-market sale Nurix Therapeutics, Inc.NRIX 400,216, disposed Open Form 4 filing 0001549595-24-000088
2024-05-02 S, Open-market sale Nurix Therapeutics, Inc.NRIX 44,878, disposed Open Form 4 filing 0001549595-24-000057
2024-04-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 16,703, disposed Open Form 4 filing 0001549595-24-000055
2024-02-16 S, Open-market sale Nurix Therapeutics, Inc.NRIX 68,223, disposed Open Form 4 filing 0001549595-24-000034
2024-01-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 13,352, disposed Open Form 4 filing 0001549595-24-000009
2023-12-20 S, Open-market sale Nurix Therapeutics, Inc.NRIX 35,421, disposed Open Form 4 filing 0001549595-23-000066
2023-12-19 S, Open-market sale Nurix Therapeutics, Inc.NRIX 109,093, disposed Open Form 4 filing 0001549595-23-000064
2023-10-31 S, Open-market sale Nurix Therapeutics, Inc.NRIX 5,613, disposed Open Form 4 filing 0001549595-23-000060
2023-07-31 S, Open-market sale Nurix Therapeutics, Inc.NRIX 12,020, disposed Open Form 4 filing 0001209191-23-043982
2023-05-01 S, Open-market sale Nurix Therapeutics, Inc.NRIX 7,121, disposed Open Form 4 filing 0001209191-23-026522
2023-01-30 S, Open-market sale Nurix Therapeutics, Inc.NRIX 10,884, disposed Open Form 4 filing 0001209191-23-005908
2022-10-31 S, Open-market sale Nurix Therapeutics, Inc.NRIX 9,519, disposed Open Form 4 filing 0001209191-22-055146
2022-08-01 S, Open-market sale Nurix Therapeutics, Inc.NRIX 11,784, disposed Open Form 4 filing 0001209191-22-043962
2022-05-02 S, Open-market sale Nurix Therapeutics, Inc.NRIX 8,190, disposed Open Form 4 filing 0001209191-22-026890
2021-02-24 S, Open-market sale Nurix Therapeutics, Inc.NRIX 1,413,218, disposed Open Form 4 filing 0001209191-21-014307
2021-02-22 S, Open-market sale Nurix Therapeutics, Inc.NRIX 212,839, disposed Open Form 4 filing 0001209191-21-013353
2021-02-18 S, Open-market sale Nurix Therapeutics, Inc.NRIX 5 lines 481,621, disposed Open Form 4 filing 0001209191-21-012668

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 45
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. van Houte Hans, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001817217

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.